B-type natriuretic levels in critically ill patients: critically misleading?
Although B-type natriuretic peptide (BNP) has been used for the diagnosis of congestive heart failure in many clinical settings, its diagnostic role in critically ill patients remains uncertain. The body of literature suggests that BNP and N-terminal pro-BNP levels are not useful for the diagnosis of systolic or diastolic heart failure in the critically ill, including in patients with brain hemorrhage, due to poor specificity. However, these cardiac peptides may have a more promising prognostic role in this patient population.
ACESSO AO ARTIGOhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2750141
- High levels of B-type natriuretic peptide predict weaning failure from mechanical ventilation in adult patients after cardiac surgery
- Are B‐type natriuretic peptide (BNP) and N‐terminal‐pro‐BNP useful in neonates?
- B‐type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans
- How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
- B-type natriuretic peptide as a predictor of anterior wall location in patients with non-ST-elevation myocardial infarction